Intl. Biotechnology Trust PLC Latest Factsheet and Blog

RNS Number : 3124M

Intl. Biotechnology Trust PLC

29 April 2024

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 31 March 2024 is now available directly via its website. Please click here, then 'latest factsheet'.

 

The global healthcare industry benefits from several fundamental tailwinds that look capable of driving structural growth for many years, if not decades, into the future. The increasingly complex demands of a global population that is growing older, richer and sicker, are driving steadily rising demand for pharmaceutical products and the industry is responding with accelerating innovation.

 

This topic is explored in  the latest blog post, Older, richer, sicker - the implications of global demographic megatrends on the biotech opportunity, from IBT's investment managers Ailsa Craig and Marek Poszepczynski, which can be read here: https://www.schroders.com/en-gb/uk/individual/content/older-richer-sicker-the-implications-of-global-demographic-megatrends-on-the-biotech-opportunity/

 

To sign up for IBT updates by email, please click here.

 

 

ENDS

 

 

Enquiries:

 

Schroder Investment Management Limited   Augustine Chipungu (Press) Kirsty Preston   Kerry Higgins (Company Secretary)	​ 020 7658 6000     020 7658 6000
Kaso Legg Communications (Financial PR)   Charles Gorman Henry Taylor Effie Aye Maung Hider	​ ​   [e-mail]

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRABVLLLZZLFBBZ